SEC Form 4 · accession 0001144204-18-020872
OPIANT PHARMACEUTICALS, INC. · OPNT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Geoffrey Wolf
10% Owner
Period of report
Apr 8, 2018
Accepted (ET)
Apr 17, 2018 · 12:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001385508
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $.001 par value per shareF1 | Apr 8, 2018 | G | 90,000 | $0.00 | D | 124,500 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This was a bona fide gift with no payment consideration.